Skip to main content

OptimizeRx Corp

OPRX
Exchange
Nasdaq
Industry
Services-Business Services, NEC
SEC CIK
0001448431

No open-market purchases or sales by OptimizeRx Corp insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $64.2M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding OptimizeRx Corp changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of OPRX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders125129+4
Shares13.4M13.3M−6.42K (0.0%)
Value$273.7M$163.9M−$109.8M (−40.1%)

New holders (26)

Institutions that held OptimizeRx Corp at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to OPRX in Q4 2025
InstitutionSharesValue% of portfolio
CWM Advisors, LLC95,880$1.18M0.11%
Credit Agricole S A89,200$1.09M0.00%
Jane Street Group, LLC87,481$1.07M0.00%
SEI Investments Co53,789$659.5K0.00%
Millennium Management LLC43,669$535.4K0.00%
Diametric Capital, LP33,263$407.8K0.11%
Susquehanna International Group, LLP29,741$364.6K0.00%
GWN Securities Inc.22,358$274.1K0.06%
Engineers Gate Manager LP18,634$228.5K0.00%
HRT Financial LP17,295$212.0K0.00%
Independent Financial Group, LLC16,500$202.3K0.00%
Canada Pension Plan Investment Board13,900$170.4K0.00%
Campbell & CO Investment Adviser LLC12,908$158.3K0.01%
Gsa Capital Partners LLP12,604$155.0K0.01%
ExodusPoint Capital Management, LP12,252$150.2K0.00%
Point72 Asset Management, L.P.11,965$146.7K0.00%
Prelude Capital Management, LLC11,063$135.6K0.01%
Quantbot Technologies LP9,847$120.7K0.00%
State of Alaska, Department of Revenue5,067$62.0K0.00%
Bard Associates Inc1,480$18.1K0.00%
UBS Asset Management Americas Inc639$7.83K0.00%
Northwestern Mutual Wealth Management Co100$1.23K0.00%
Torren Management, LLC97$1.19K0.00%
Rothschild Investment LLC5$610.00%
IFP Advisors, Inc2$250.00%
Pinnacle Wealth Planning Services, Inc.1$120.00%

Sold out (22)

Institutions that held OptimizeRx Corp at the end of Q3 2025 and filed for Q4 2025 without it.